Treatment-free remission in CML: who, how, and why?

FX Mahon - Hematology 2014, the American Society of …, 2017 - ashpublications.org
Chronic myeloid leukemia (CML) is the best example of successful targeted therapy. Today,
the overall survival of patients with CML treated by using tyrosine kinase inhibitors (TKIs) is …
被引用次数：100 相关文章

Treatment-free remission in CML: who, how, and why?

FX Mahon - Hematology. American Society of Hematology …, 2017 - pubmed.ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is the best example of successful targeted therapy. Today,
the overall survival of patients with CML treated by using tyrosine kinase inhibitors (TKIs) is …

Treatment-free remission in CML: who, how, and why?

FX Mahon - Hematology, 2017 - cir.nii.ac.jp
抄録< jats: p> Chronic myeloid leukemia (CML) is the best example of successful targeted
therapy. Today, the overall survival of patients with CML treated by using tyrosine kinase …
[HTML] nih.gov

[HTML][HTML] Treatment-free remission in CML: who, how, and why?

FX Mahon - Hematology: the American Society of Hematology …, 2017 - ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is the best example of successful targeted therapy. Today,
the overall survival of patients with CML treated by using tyrosine kinase inhibitors (TKIs) is …

Treatment-free remission in CML: who, how, and why?

FX Mahon - … . American Society of Hematology. Education Program, 2017 - europepmc.org
Chronic myeloid leukemia (CML) is the best example of successful targeted therapy. Today,
the overall survival of patients with CML treated by using tyrosine kinase inhibitors (TKIs) is …